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Abstract
Background and Purpose—No studies have determined the effect of differences in pial 
collateral extent (number and diameter), independent of differences in environmental factors and 
unknown genetic factors, on severity of stroke. We examined ischemic tissue evolution during 
acute stroke, as measured by magnetic resonance imaging (MRI) and histology, by comparing 2 
congenic (CNG) mouse strains with otherwise identical genetic backgrounds but with different 
alleles of the Determinant of collateral extent-1 (Dce1) genetic locus. We also optimized magnetic 
resonance (MR) perfusion and diffusion deficit thresholds by using histological measures of 
ischemic tissue.
Methods—Perfusion, diffusion, and T2-weighted MRI were performed on collateral-poor (CNG-
Bc) and collateral-rich (CNG-B6) mice at 1, 5 and 24h after permanent middle cerebral artery 
occlusion (pMCAo). MRI-derived penumbra and ischemic core volumes were confirmed by 
histology in a subset of mice at 5 and 24h after pMCAo.
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Results—Although perfusion deficit volumes were similar between strains 1h after pMCAo, 
diffusion deficit volumes were 32% smaller in collateral-rich mice. At 5h, collateral-rich mice had 
markedly restored perfusion patterns showing reduced perfusion deficit volumes, smaller infarct 
volumes, and smaller perfusion-diffusion mismatch volumes compared with the collateral-poor 
mice (p<0.05). At 24h, collateral-rich mice had 45% smaller T2-weighted lesion volumes 
(p<0.005) than collateral-poor mice, with no difference in perfusion-diffusion mismatch volumes 
because of penumbral death occurring 5 to 24h after pMCAo in collateral-poor mice.
Conclusions—Variation in collateral extent significantly alters infarct volume expansion, 
transiently affects perfusion and diffusion MRI signatures, and impacts salvage of ischemic 
penumbra after stroke onset.
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Introduction
Collateral vessels are anastomoses that connect adjacent arterial trees and reroute perfusion 
around obstructed arteries or veins. Variation among individuals in the extent of native 
collaterals (i.e., number and/or diameter) may serve as a prognostic determinant of stroke 
severity and improve clinical risk-benefit decisions for treatment options.1, 2 Angiographic 
studies grading collateral circulation in patients with acute stroke have found that final 
infarct size3, 4 and functional outcome deficit vary inversely with collateral flow.5–7 Patients 
with robust collateral circulation also have improved outcomes after tissue-type plasminogen 
activator (tPA) administration4 (including reduced risk of hemorrhaging8) and/or intra-
arterial revascularization,9–11 suggesting that collateral extent significantly impacts the 
success of therapeutic interventions for acute ischemic stroke.
Imaging of perfusion in acute stroke patients using computed tomography (CT) or magnetic 
resonance imaging (MRI) is routine for accurate diagnosis and volumetric assessments of 
ischemic tissue. Contrast-enhanced CT,3 MRI12 and arterial spin-labeled perfusion 
MRI13, 14 are also used clinically to differentiate hemorrhagic stroke and assess collateral 
status. Ischemic stroke registries that centrally store these data have been used 
retrospectively to examine how collateral circulation alters lesion evolution.3, 7, 12, 15, 16 
Such analyses consider many outcome-modifying variables (e.g., age, sex, co-morbidities, 
vascular risk factors, type/time of therapeutic intervention). However, they cannot account 
for all variables that contribute to acute stroke heterogeneity, resulting in conclusions based 
on correlation rather than causation. Recently, a novel mouse model has been developed that 
permits examination of the contribution of variation in collateral extent on variation in lesion 
progression, because genetic and environmental differences are controlled.17 Two congenic 
(CNG) mouse lines were constructed that are isogenic except at a discrete locus on 
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chromosome 7, Determinant of collateral extent-1 (Dce1), whose allelic variants determine 
85% of the wide variation in collateral extent present in different inbred mouse strains: 
CNG-Bc are congenic wild-type BALB/cByJ (Bc) mice with sparse, small-diameter pial 
collaterals, while CNG-B6 are congenic Bc mice that harbor the C57BL/6J (B6) allele of 
Dce1, resulting in abundant, large-diameter collaterals. Because these mice differ only in 
collateral extent, they provide a unique opportunity to examine the role of collaterals, per se, 
on stroke progression.
In this study, congenic mice were subjected to pMCAo to determine how differences in 
collateral extent affect ischemic tissue evolution. We used perfusion, diffusion, and T2-
weighted MRI techniques that are commonly used to characterize ischemic core and 
estimate penumbra.18–21 To more specifically assess the role of collaterals and exclude 
confounding reperfusion factors, we used MRI at 1, 5, and 24h after pMCAo. To corroborate 
the MR findings, we performed cleaved caspase-3 (CC3) and heme oxygenase-1 (HO-1) 
immunohistochemistry in a subset of animals to quantify ischemic core and penumbra, 
respectively. Additionally, we also used this unique dataset to derive specific MR apparent 
diffusion coefficient (ADC) and cerebral blood flow (CBF) deficit thresholds that best 
approximate histological ground truth. Compared with collateral-poor CNG-Bc mice, the 
collateral-rich CNG-B6 mice showed significantly smaller ADC deficit volume, CBF deficit 
volume, and more rescued penumbral tissue. Our data demonstrate that collateral extent is a 
key determinant of infarct evolution in mice and, if confirmed in humans, should be 
considered as an outcome-modifying variable in stroke clinical trials.
Materials and Methods
Animal Preparation
Two congenic mouse strains on the Bc background with distinct pial collateral extent 
profiles (Figure 1, see Introduction) were studied (n=22/strain, male, 3–4 months-age).17 
Following an overnight fast, mice were anesthetized with 1.5–2% isoflurane and their 
respective rectal temperature, blood O2 saturation, and pulse/respiration rates were 
monitored using a MouseOx Plus (STARR Life Science Corp., Oakmont, PA) and 
maintained at 37±0.5°C, >97%, 380±10 bpm/100±10 bpm during surgery and scanning. A 2 
mm aseptic craniotomy was performed and pMCAo was performed by cauterization at the 
M2-MCA level.22 The craniotomy was closed with gelfoam (Pfizer Inc, 0009-0396-05, New 
York, NY) and dental cement to avoid susceptibility artifact during MR scans. After pMCAo 
mice were maintained in the scanner under 0.75–1% isoflurane delivered in 25% O2 at a 
flowrate of 1 L/min. A subset of mice were scanned only once at either 1h (n=9/congenic 
strain), 5h or 24h (n=4/ congenic strain) after pMCAo for histological assessment. The 
remaining subjects underwent longitudinal scans. All studies were approved by the 
Institutional Animal Care and Use Committee of the University of North Carolina at Chapel 
Hill.
Magnetic Resonance Imaging Acquisition
MRI data were acquired using a Bruker BioSpec 9.4 Tesla system with a BGA-9S gradient 
insert (Bruker Corp., Billerica, MA). A home-made surface coil (with an internal diameter 
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of 0.8 cm) was used for brain imaging. For CBF measurement, an additional actively 
decoupled heart coil was used for continuous cardiac spin labeling (CSL).23 This was 
achieved by a two-shot gradient-echo echo-planar imaging (EPI) sequence with 
bandwidth=300 kHz, TR/TE=3000/5 ms, labeling duration=2.524 s, post-labeling delay=300 
ms, matrix=64x64, FOV=1.6x1.6 cm, 10 slices and slice thickness=0.75 mm. Diffusion-
weighted images were acquired with the same geometry using two-shot spin-echo EPI with 
bandwidth=300 kHz, TR/TE=3000/22 ms, δ/Δ=4/12 ms, number of B0=5, number of 
directions=30 and b-value=1200 s/mm2. T2-weighted anatomic images were acquired using 
a RARE sequence with spectral width=47 kHz, TR/TE=2500/44 ms, matrix=144x144, 
RARE factor=8, number of averages=20, FOV=1.44x1.44 cm, 10 slices and slice 
thickness=0.75 mm.
Histological Confirmation of the Ischemic Lesion
Because no reliable histological biomarker can delineate the border zone between penumbra 
and ischemic core within the first hour of stroke, stereological morphometric analysis was 
performed on a subset of mice at 5 and 24h after pMCAo (n=5/congenic strain/end point). 
Mice were euthanized by Euthasol overdose (100 mg/kg, i.p.) and transcardially perfused 
with 25 mL of 1x PBS (pH 7.2) followed by 25 mL of 4% PFA. Extracted brains were 
postfixed in 4% PFA overnight, followed by 30% sucrose until they sank and frozen to a 
chilled sliding microtome. Serial 30 μm-thick coronal sections were sliced between +2.2 mm 
anterior and −4.5 mm posterior of Bregma (as determined by atlas-derived landmarks), 
collecting only one of every 10 sections (21–23 sections/mouse/marker) for free floating 
immunohistochemistry. Sections were initially incubated in a MOM kit (PK-2200 Vector 
Laboratories, Burlingame, CA) according to the manufacturer’s protocol or blocking 
solution (1% Bovine Serum Albumin, 0.4%Triton X-100 and 4% Normal Goat Serum in 
PBS) for 20 minutes to block non-specific binding. Sections were immunostained overnight 
at 4°C with either the penumbral marker mouse monoclonal antibody against heme 
oxygenase-1 (HO-1; 1:50, Enzo Life Science, ADI-OSA-110, Farmingdale, NY) or the 
ischemic core marker rabbit polyclonal antibody against cleaved caspase-3 (CC3; 1:100, 
Cell Signaling, 9661, Danvers, MA) and visualized with Alexa Fluor secondary antibodies 
(1:800; Molecular Probes, Carlsbad, CA). Volumes of ischemic core, penumbra and non-
immunoreactive tissue were quantified stereologically using the Cavalieri estimator method 
on Stereo Investigator (v7.5; MBF Bioscience, Microbrightfield, Inc., Williston, VT) and 
corrected for dehydration-related shrinkage in slice thickness and edema using the ‘indirect 
method’.24 Systematic random samples were unbiasedly counted in 50 μm2 frames within 
manually defined boundaries of each hemisphere using a 10 μm optical dissector with 2 μm 
upper and lower guard zones. Stereological imaging was performed with an Olympus BX50 
microscope using a 60x 1.4 NA oil-immersion objective with a calculated coefficient of 
error of intra-animal variation of less than 0.1.
Data Processing and Analysis
Image analysis was performed using Statistical Parametric Mapping (SPM) in a custom-
written Matlab (MathWorks Inc., Natick, MA) script.25 Images were skull-stripped, co-
registered across subjects and analyzed using established protocols that we published 
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previously.26, 27 Specifically, CBF was calculated from CSL data using , 
where SC and SL are the MR signal intensities from the control and labeled images, 
respectively. λ is the water brain-blood partition coefficient, T1 is that of tissue, and α is the 
arterial spin-labeling efficiency. For λ, T1, and α we used 0.9, 1.9, and 0.7s, respectively.28 
Apparent diffusion coefficient (ADC) maps were calculated from the diffusion weighted 
images using , where S1 is the signal intensity obtained at b1 (1200 s/mm2) 
and S0 is the signal intensity obtained at b0 (0 s/mm2). Group-averaged CBF, ADC, and T2-
weighted images for each experimental group and time-point were presented.
To better identify a specific ADC or CBF threshold reflecting histological measure, a range 
of ADC (0.45–0.6 mm2/s) and CBF (0.175–0.35 ml/g/min) thresholds was used to compute 
their respective deficit volumes that underwent best-fit correlations with respect to 
histologically-defined volumes using an established method.29 ADC and CBF deficit 
thresholds were calculated using Euclidean distances between true histologically-defined 
and threshold-dependent MRI volumes. Polynomial curves up to a degree of 4 were fitted to 
predict distances at unmeasured threshold values and the curve that best balanced over- and 
under-fitting the two volumes were selected as the optimal threshold cut-off for ADC and 
CBF deficits.
The values in the ipsilesional hemisphere were calculated based on the MR perfusion and 
diffusion deficits that delineated with our histologically guided thresholds, while the values 
in the contralesional hemisphere were measured with size-matched mirror-ROIs. T2-
weighted lesion volumes were quantified by thresholding hyper-intense signals (≥2 SD of 
contralateral normal cortical tissue) as described previously.26 The ratio of MR-derived 
penumbral loss was defined as the difference in ADC deficit volumes between two time 
points divided by the mismatch volume at 1h.15 The ratio of infarct growth was defined as 
the difference in ADC deficit volumes between the two time points divided by the T2-
weighted lesion volume at 24h.15
Statistical analysis was performed using SPSS software (IBM SPSS statistics 21, IBM 
Corp., Armonk, NY). To compare the difference in the deficit volumes between two 
congenic strains at multiple time points, unpaired two-way ANOVA followed by Tukey’s 
HSD and Scheffe post hoc test was performed for data-passing and not-passing homogeneity 
test, respectively. Significant difference in ADC or CBF value, the ratio of penumbra tissue 
loss and the ratio of infarct growth between the two congenic strains at a particular time-
point was assessed by a two-tailed independent t-test. All data in text are presented as mean
±SEM.
Results
Physiological parameters remained consistent throughout the MRI scans at 1, 5 and 24h 
after pMCAo. Beause no significant difference in CBF and ADC intensities or volumes were 
observed 24h after pMCAo within congenic mice that either received a single scan (n=4 per 
strain) or longitudinal scans (n=5 per strain in the cohort for 5h and 24h multiple scans), data 
collected for each time-point were compiled together for analysis. One CNG-Bc mouse was 
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excluded from the data because of a negative mismatch volume detected 5h after pMCAo, 
likely because of artifact during imaging acquisition. Figure 2 shows group-averaged CBF, 
ADC, and T2-weighted images for each time-point in CNG-B6 (n=9 per time-point) and 
CNG-Bc mice (n=9 at 1 and 24h, n=8 at 5h) after pMCAo. By using a within-subject 
comparison with histological data, we identified ADC and CBF deficit thresholds of 0.541 
mm2/s and 0.255 ml/g/min after pMCAo best approximated the tissue deficit volume defined 
by CC3 (necrotic / apoptotic cells) and CC3+HO-1 (necrotic / apoptotic cells + penumbra) 
expression, respectively (Figure 3A,B). These thresholds were used for subsequent analyses. 
With these optimized thresholds, we also found significant correlations between ADC deficit 
and CC3 lesion volumes (Figure 3C) and also CBF deficit and CC3+HO-1 lesion volumes 
(Figure 3D).
At 1h after pMCAO we observed marked reductions in CBF values in the lesion side 
compared with the contralesional (normal) hemisphere as expected (Figure 4A). We 
observed no significant differences in the MR-derived CBF deficit volume at this time-point 
(Figure 5A). The mean ADC values were not different between the two groups, but ADC 
deficit volumes were significantly smaller in CNG-B6 (15.957±1.305 mm3) than CNG-Bc 
(23.325±4.592 mm3; p<0.005; Figure 5B). No significant difference in perfusion-diffusion 
mismatch volumes was found at 1h (16.562±6.817 mm3 for CNG-B6 and 14.370±7.372 
mm3 for CNG-Bc; p>0.05; Figure 5C). Additionally, no differences were observed between 
congenic strains in T2-weighted infarct volume at 1h (Figure 5C,D), likely because of the 
low sensitivity of this method to detect ischemic tissue during the hyperacute phase of 
pMCAo.
At 5h after pMCAo CBF deficit volumes were significantly reduced in collateral-rich CNG-
B6 (19.692±5.208 mm3) compared with collateral-poor CNG-Bc mice (32.425±8.213 mm3; 
p<0.005; Figure 5A), suggesting significant restoration of tissue perfusion by collaterals. 
The mean ADC values were not different between the two groups, but ADC deficit volumes 
were significantly smaller in CNG-B6 (16.165±3.212 mm3) than CNG-Bc (24.481±4.777; 
p<0.005; Figures 5B). A significantly smaller perfusion-diffusion mismatch in CNG-B6 was 
observed (3.528±2.596 mm3 compared with 10.758±7.661 mm3 in CNG-Bc; p<0.05; Figure 
5C). The infarct volume defined by T2-weighted images in CNG-B6 (9.876±1.883 mm3) 
was also significantly smaller than CNG-Bc (16.327±3.516 mm3; p<0.005; Figure 5D). No 
significant difference in the loss of perfusion-diffusion mismatch tissue (1.257±6.854 mm3 
for CNG-B6 and 8.047±11.754 mm3 for CNG-Bc; p>0.05; Figure 6A), as well as the growth 
of T2-weighted lesion volume (1.149±2.939 mm3 for CNG-B6 and 3.484±5.089 mm3 for 
CNG-Bc; p>0.05; Figure 6B), were found from 1 to 5h.
At 5h after pMCAo the CBF deficit volumes remained significantly reduced in collateral-
rich CNG-B6 (19.370±5.179 mm3) compared with those in collateral-poor CNG-Bc mice 
(32.021±8.957 mm3; p<0.005; Figures 5A). The mean ADC values were not different 
between the two groups, but ADC deficit volumes were significantly smaller in CNG-B6 
(17.379±5.945 mm3) than CNG-Bc (28.713±3.6826 mm3; p<0.005; Figures 5B). No 
significant difference in perfusion-diffusion mismatch volumes was found (1.473±1.245 
mm3 for CNG-B6 and 3.331±2.648 mm3 for CNG-Bc; p>0.05; Figure 5C). The infarct 
volume defined by T2-weighted images in CNG-B6 (18.133±4.231 mm3) was significantly 
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smaller than CNG-Bc (33.527±3.829 mm3; p<0.005; Figure 5D). In addition, loss of 
perfusion-diffusion mismatch tissue (approximate penumbra) from 5 to 24h became 
significantly different between CNG-B6 (6.532±7.697%) and CNG-Bc (36.376±8.289%). 
The growth of T2-weighted lesion volume also differed between CNG-B6 (6.137±3.225%) 
and CNG-Bc (15.076±2.229%) (both p<0.05; Figures 6A,B).
Discussion
The present study sought to differentiate the contribution of variation in pial collateral 
circulation to the evolving perfusion and diffusion MRI signals within the first 24h after 
acute stroke. Using congenic mouse strains that differ solely in their collateral extent, we 
report that: (1) Genetic specification of “poor” versus “good” collaterals alters the initial 
ADC deficit volumes and the ability to salvage ‘at-risk’ tissue within 5h after stroke. (2) 
Although CBF deficit volume does not differ between the two congenic strains at 1h after 
pMCAo, collateral perfusion in collateral-rich mice is higher and sufficient to restrict 
expansion of initial ADC deficit volume. (3) Within 5h after pMCAo, collateral-rich mice 
display small CBF deficit volume, resulting in significant rescue of penumbra; while 
collateral-poor mice experience a larger area that remains at-risk, demonstrating that 
collateral extent plays a major role in altering the outcome of the second wave of cell death 
during permanent focal ischemia. (4) The imaging protocols and ADC/CBF thresholds 
established herein in mice demonstrate sufficient sensitivity and specificity to detect 
ischemic tissue evolution and thus offer a technical foundation for future studies 
investigating the efficacy of “collateral therapeutics”.
Wide variation in collateral extent among 21 inbred mouse strains is found to be tightly 
correlated with similarly wide variation in infarct volume after pMCAo and links to variants 
of the Dce1 locus in these strains,22, 30 suggesting that genetic polymorphisms underlying 
differences in collateral extent may be important risk factors for poor stroke outcome. 
However, other gene variants not associated with differences in collateral extent can also 
alter stroke severity, including the expression and activity of proteins that could affect infarct 
progression post-stroke. In addition, uncontrollable physiological differences between wild-
type mouse trains, for instance, mean arterial pressure and immune response, might 
contribute to lesion evolution. The use of congenic mice with genetic variability restricted to 
a single locus shown to be the major determinant of anatomic variation in collaterals in mice 
allowed us to test for causation between collateral extent and the severity of the ischemic 
lesion and its evolution. To our knowledge, this is the first study to dissect the causal role of 
collateral extent, per se, in ischemic lesion evolution during the hyperacute, acute and early-
chronic phases after pMCAo. Permanent MCAo in mice immediately reduces averaged CBF 
in the MCA territory by 50%,31 and irreversibly results in necrotic death within minutes in 
regions where perfusion drops by ≥80%.32 Permanent MCAo in both congenic lines resulted 
in significant reductions in CBF, yet mean CBF within perfusion deficit volumes were 
significantly greater in collateral-rich compared with collateral-poor mice 1h after stroke 
onset (40.69±4.31% and 38.23±2.05%, respectively) and reduced the initial ischemic core 
volume by 31.50% as defined by ADC deficit thresholds. This immediate retrograde 
collateral perfusion of the MCA territory is established within seconds after occlusion 
because of the large increase in cerebral perfusion pressure (CPP) across the collateral 
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network.33, 34 Although mathematical models have predicted that pial collaterals can 
continue to maintain 15% of overall MCA baseline CBF immediately after pMCAo,35 
retrograde collateral perfusion to the proximal MCA territory is insufficient to preserve 
cellular function during this hyperacute phase, resulting in death for most cells in this region 
if CBF is not sufficiently restored.
At 5h after pMCAo, a significantly smaller CBF deficit volume was found in collateral-rich 
CNG-B6 mice compared with their collateral-poor counterparts. Studies in mice have shown 
that during the first few hours of collateral perfusion, presumed fluid shear stress-mediated 
dilation results in a 26% increase in collateral diameter after major vessel occlusion. 
Collaterals subsequently undergo outward remodeling of lumen diameter that requires 3–6 
days, depending on genetic background, to achieve maximal remodeling (~2-to-4-fold 
increase in anatomic lumen diameter).22 Changes in smooth muscle tone, plus the initial 
driving force of CPP across the collateral network induced by occlusion, are the primary 
determinants of collateral blood flow during the acute phase of pMCAo. However, further 
changes in collateral flow induced by alterations in CPP, such as those produced by 
downstream collapse of the venous network from insufficient inflow, will also impact 
delivery of oxygen to the territory at risk.33, 36 The lack of change in ADC threshold 
volumes between 1 and 5h after pMCAo in collateral-rich mice, coupled with a significant 
reduction in perfusion-diffusion mismatch volume, indicates that collateral circulation can 
rescue penumbral tissue from death. On the other hand, in the collateral-poor mice, 
collateral flow is insufficient to prevent the second wave of cellular death resulting from an 
inability to restore adequate circulation to the entire MCA penumbral territory. Using the 
oxidative stress marker HO-1 expressed in penumbral tissue after pMCAo,37 we found that 
mismatch of perfusion deficit volumes below 0.255 ml/g/min and diffusion deficit volumes 
below 0.541 mm2/s accurately estimate penumbral volume in both congenic strains.
Infarct volume at 24h after pMCAo, as confirmed by ADC deficit volumes and T2-weighted 
imaging, was significantly smaller in collateral-rich mice. The perfusion-diffusion mismatch 
volumes of both congenic strains were found to be less than 5 mm3, which is consistent with 
the small penumbral volumes delineated by suppressed cerebral protein synthesis with 
preserved ATP production 8h after pMCAo in mice.38 Our detection of a significant 
divergence of ADC and CBF deficit volumes between congenic strains demonstrates that 
collateral circulation dictates initial infarct size, infarct expansion, and whether penumbral 
tissue will be rescued. Multimodal MRI techniques are improving the efficiency of clinical 
stroke diagnosis and allow rapid estimation of penumbral tissue volume as early as the acute 
phase of ischemic stroke, which is important in balancing the risk versus benefit of 
reperfusion therapy.39, 40 The controversy surrounding the use of perfusion-diffusion 
mismatch to indicate penumbra and the course of stroke treatment is in part attributed to the 
lack of consistency in defining deficit thresholds, overestimation of the tissue at risk, 
assumption of the irreversible diffusion lesions, and differences in the parameters used 
during acquisition.40–42 Furthermore, the dynamic nature and heterogeneous distribution of 
the penumbra can cause significant fluctuations in perfusion and diffusion deficit volumes 
during acute stroke43, 44—variation that is only accentuated when collateral extent varies 
among subjects.6, 7, 45 Our findings suggest caution to be taken when referring to the 
“penumbra” or “perfusion-diffusion mismatch volume” at a fixed time-point as a prognostic 
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or treatment criteria, without carefully considering the role of collateral circulation and the 
consequent temporal evolution of ischemic penumbra.
Mouse perfusion and diffusion MRI have many challenges, including strong susceptibility 
artifacts and lack of commercially available hardware for high-quality two-coil ASL.23, 46, 47 
More importantly, no “gold-standard” ADC and CBF thresholds exist for probing ischemic 
tissue in rodents. We addressed these problems herein by optimizing our thresholds against 
histologically-defined volumes, leading to a strategy for mapping the evolution of ischemic 
tissue in mice. One limitation of our study is that T1 relaxation times increase after stroke 
and may result in decreased CBF signals.48, 49 Thus, even though mismatch volumes in our 
study may better approximate penumbra volumes in mice with different collateral extents, 
they may not represent the absolute size of ischemic penumbra.
Conclusions
In summary, we performed quantitative perfusion and diffusion MRI in congenic mice 
differing in collateral extent to investigate the relationship between the ischemic penumbra 
and the vigor of the collateral circulation. Our findings using mice with identical genetic 
background but with congenically specified “good” versus “poor” collaterals demonstrate 
that the presence of good collaterals results in penumbral salvage within the first 5h of 
pMCAo followed by reduced perfusion-diffusion mismatch tissue loss during the 5–24h 
period. The results demonstrate the utility of this mouse model to explore the development 
of therapeutic strategies to enhance collateral perfusion post-stroke onset.50 Additional 
studies combining this genetic mouse model with transient MCAo followed by post-labeling 
delays, will allow investigation of how reperfusion interacts with inherent differences in 
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Figure 1. Genetic model of abundant versus sparse collaterals: congenic-B6 and congenic-Bc 
mice
Maximally dilated pre-capillary vessels filled with Microfil shows larger collateral number 
in congenic (CNG)-B6 compared to CNG5-Bc. Stars, MCA-to-ACA collaterals. Inset, 
higher magnification showing presence and absence of pial collaterals in watershed zone. 
CNG-Bc, congenic-line5 wildtype BALB/cByJ mice (2±1 MCA-to-ACA collaterals of 
12±13 μm lumen diameter); CNG-B6, congenic-line5 wildtype BALB/cByJ mice with 
C57BL/6J Dce1 genetic locus introgressed into genome (14±1 MCA-to-ACA collaterals of 
20±2 μm diameter).17
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Figure 2. Perfusion and diffusion MRI and T2-weighted images in CNG-B6 and CNG-Bc mice 
after permanent MCAo (pMCAo)
Group-averaged CBF map (A), ADC map (B), and T2-weighted images (C) at 1, 5 and 24 h 
after pMCAo. Hypoperfused area was observed in the entire ipsilesional cortex at 1 h in both 
CNG-B6 and CNG-Bc mice. After 24 h, larger CBF, ADC deficit and final infarct area 
evident in anterior and posterior cortical regions in CNG-Bc.
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Figure 3. Lesion volumes defined by histological staining and comparison with MRI (C,D)
Optimal threshold of ADC- (A) and CBF-derived (B) lesion volumes based on the curve 
fitting. Histological staining: cleaved caspace3 (CC3), heme oxygenase-1 (HO-1).
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Figure 4. CBF and ADC values in CNG-B6 and CNG-Bc mice
(A) CBF and (B) ADC values in corresponding lesion volume at 1, 5 and 24 h after pMCAo. 
No significant change in CBF or ADC in contralesional hemisphere in both strains. 
Significantly higher CBF present in lesion area in CNG-B6 1h after pMCAo. Mean±SEM; 
*p<0.05 versus CNG-Bc.
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Figure 5. CNG-B6 mice shows smaller CBF deficit, ADC deficit, mismatch and T2-weighted 
lesion volumes after pMCAo
Mean±SEM; *,**p<0.05,<0.005 versus CNG-Bc; #,##p<0.05,<0.005 versus time.
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Figure 6. CNG-B6 shows smaller perfusion-diffusion mismatch tissue loss and T2-weighted 
lesion volume growth after pMCAo
Mean±SEM; *p<0.05 versus CNG-Bc.
Kao et al. Page 18
Stroke. Author manuscript; available in PMC 2018 March 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
